West Pharma (WST) Reports Q3 EPS of $0.44
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $407.88 -1.15%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q3 EPS of $0.44, versus $0.44 reported last year. Revenue for the quarter came in at $344.5 million, versus $355.9 million reported last year.
West Pharma sees FY2015 EPS of $1.79-$1.84.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Voyager Technologies, Inc. (VOYG) Misses Q3 EPS by 55c; Offer Guidance
- National Presto Indust. (NPK) Reports Q3 EPS of $2.79
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
